Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Interest Coverage Ratio: 2009-2025

Historic Interest Coverage Ratio for Myriad Genetics (MYGN) over the last 13 years, with Sep 2025 value amounting to -6.13.

  • Myriad Genetics' Interest Coverage Ratio rose 75.47% to -6.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -61.84, marking a year-over-year decrease of 60.20%. This contributed to the annual value of -44.11 for FY2024, which is 50.31% up from last year.
  • Per Myriad Genetics' latest filing, its Interest Coverage Ratio stood at -6.13 for Q3 2025, which was up 97.21% from -219.47 recorded in Q2 2025.
  • Myriad Genetics' Interest Coverage Ratio's 5-year high stood at -6.13 during Q3 2025, with a 5-year trough of -227.40 in Q2 2023.
  • For the 3-year period, Myriad Genetics' Interest Coverage Ratio averaged around -79.16, with its median value being -55.71 (2024).
  • Per our database at Business Quant, Myriad Genetics' Interest Coverage Ratio slumped by 666.52% in 2023 and then soared by 79.94% in 2024.
  • Myriad Genetics' Interest Coverage Ratio (Quarterly) stood at -86.20 in 2021, then spiked by 32.71% to -58.00 in 2022, then soared by 39.85% to -34.89 in 2023, then tumbled by 59.69% to -55.71 in 2024, then skyrocketed by 75.47% to -6.13 in 2025.
  • Its Interest Coverage Ratio stands at -6.13 for Q3 2025, versus -219.47 for Q2 2025 and -36.25 for Q1 2025.